Skip to content

Psychedelic-assisted therapy: Magical thinking or a meaningful treatment for mental illness

Megha Kodancha

UCC Student Medical Journal September 4, 2024 DOI: 10.33178/smj.2024.1.13 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Review Peer reviewed
Topics Psychedelic-assisted therapy
Key findings Psychedelics such as LSD, psilocybin, and MDMA show potential benefits for treating addiction, palliative care, and PTSD, respectively.

Abstract

Psychedelics are psychoactive substances that are known to alter perception, alter mood, and affect numerous cognitive processes. Throughout history, psychedelics were utilized in ceremonies and rituals, and in the 20th century, their utilization in psychiatry began. In the 1960s they became a banned substance and are only recently being revisited for their benefits. The main forms of psychedelic substances being studied today are Lysergic acid diethylamide (LSD) for addiction therapy, Psilocybin for palliative care, and 3,4-Methylenedioxymethamphetamine (MDMA) for post-traumatic stress disorder (PTSD). This paper focuses on the benefits of utilizing psychedelics for specific psychiatric conditions and is meant to encourage further research into this domain of Psychiatry.